The Archive · A Source

XOSPATA Approved by U.S. FDA

Astellas / PRNewswire 2018 www.prnewswire.com/news-releases/xospata-gilteritinib-approved-by-us-fda-for-adult-patients-with-relapsedrefractory-acute-myeloid-leukemia-aml-with-a-flt3-mutation-300757323.html